Table IV.
Association between RNF2+P-AKT expression and the clinicopathological variables of patients with esophageal squamous cell carcinoma.
| RNF2/P-AKT expression | |||||
|---|---|---|---|---|---|
| RNF2/P-AKT both positive | Other | ||||
| Variables | (n=50) | % | (n=30) | % | P-value |
| Sex | |||||
| Male | 37 | 74.00 | 12 | 40.00 | 0.003 |
| Female | 13 | 26.00 | 18 | 60.00 | |
| T stage | |||||
| 1 | 0 | 0.00 | 2 | 6.67 | 0.065 |
| 2 | 17 | 34.00 | 8 | 26.67 | |
| 3 | 6 | 12.00 | 8 | 26.67 | |
| 4 | 27 | 54.00 | 12 | 40.00 | |
RNF2, Ring finger protein 2; P-AKT, phosphor-protein kinase B; Other, including patients with RNF2/P-AKT both negative, RNF2− -P-AKT+-+++ and RNF2+-+++ -P-AKT−.